UAE Crispr And Cas Genes Market Size & Outlook, 2024-2030

The crispr and cas genes market in the UAE is expected to reach a projected revenue of US$ 41.3 million by 2030. A compound annual growth rate of 13.2% is expected of the UAE crispr and cas genes market from 2025 to 2030.
Revenue, 2024 (US$M)
$19.9
Forecast, 2030 (US$M)
$41.3
CAGR, 2025 - 2030
13.2%
Report Coverage
UAE

UAE crispr and cas genes market, 2018-2030 (US$M)

UAE

UAE crispr and cas genes market highlights

  • The UAE crispr and cas genes market generated a revenue of USD 19.9 million in 2024 and is expected to reach USD 41.3 million by 2030.
  • The UAE market is expected to grow at a CAGR of 13.2% from 2025 to 2030.
  • In terms of segment, product was the largest revenue generating product & service in 2024.
  • Service is the most lucrative product & service segment registering the fastest growth during the forecast period.

Crispr and cas genes market data book summary

Market revenue in 2024USD 19.9 million
Market revenue in 2030USD 41.3 million
Growth rate13.2% (CAGR from 2025 to 2030)
Largest segmentProduct
Fastest growing segmentService
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProduct, Service
Key market players worldwideAstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics

Other key industry trends

  • In terms of revenue, UAE accounted for 0.4% of the global crispr and cas genes market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 63.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

CRISPR And Cas Genes Market Companies

Name Profile # Employees HQ Website

UAE crispr and cas genes market size, by product & service, 2018-2030 (US$M)

UAE CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)

UAE crispr and cas genes market size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more